Viewing Study NCT06279767


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-10 @ 7:34 PM
Study NCT ID: NCT06279767
Status: RECRUITING
Last Update Posted: 2024-02-28
First Post: 2024-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Cancer View
None Temozolomide View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioblastoma View
None Cancer View
None Temozolomide View
None 6-mercaptopurine View